HealthFDA regulator defends controversial decision to approve Sarepta drug By Robert Weisman — Boston GlobeNov. 17, 2016 Reprints Tom Williams/CQ Roll Call/AP FDA regulator defends decision to approve Sarepta drug About the Author Reprints Robert Weisman — Boston Globe [email protected] @GlobeRobW
Health Tech Mohana Ravindranath and Casey Ross STAT Plus: Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
Health Tech Brittany Trang and Casey Ross STAT Plus: ‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
